1 Min Read
Nov 1 (Reuters) -
* Novartis is said to weigh sale of dermatology generics business which could fetch up to $1.5 billion - Bloomberg citing sources Source text - bloom.bg/2il88uk Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.